Journal of Pharmacology and Experimental Therapeutics: 263 (1)

October 01, 1992; Volume 263,Issue 1

You have access
Nicotinic receptor-evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels.
T Takahashi, Y Tsunoda, Y Lu, J Wiley and C Owyang

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 1-5;
You have access
Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds.
D de Cheffoy de Courcelles, K de Loore, E Freyne and P A Janssen

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 6-14;
You have access
Membrane potential in myenteric neurons associated with tolerance and dependence to morphine.
J A Leedham, J Q Kong, D A Taylor, S M Johnson and W W Fleming

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 15-19;
You have access
Opioid receptor antagonists discriminate between presynaptic mu and delta receptors and the adenylate cyclase-coupled opioid receptor complex in the brain.
A N Schoffelmeer, T J De Vries, F Hogenboom, V J Hruby, P S Portoghese and A H Mulder

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 20-24;
You have access
A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
A Yamamoto, E Hayakawa, Y Kato, A Nishiura and V H Lee

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 25-31;
You have access
Effects of intrauterine position on the hepatic microsomal polysubstrate monooxygenase and cytosolic glutathione S-transferase activity, plasma sex steroids and relative organ weights in adult male and female Long-Evans rats.
T van der Hoeven, R Lefevre and R Mankes

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 32-39;
You have access
Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: block of delayed outward potassium current.
Z H Zhang, C H Follmer, J S Sarma, F Chen and B N Singh

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 40-48;
You have access
Imipramine's selective suppression of an L-type calcium channel in neurons of murine dorsal root ganglia involves G proteins.
J J Choi, G J Huang, E Shafik, W H Wu and J J McArdle

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 49-53;
You have access
Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia.
S J Henderson and W E Lindup

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 54-60;
You have access
Release of endogenous norepinephrine from rat hypothalamus by stimulation of N-methyl-D-aspartic acid receptors.
P Blandina, D Johnson, J Walcott and J Goldfarb

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 61-68;
You have access
Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes.
D Fau, A Berson, D Eugene, B Fromenty, C Fisch and D Pessayre

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 69-77;
You have access
Flavonoid potentiation of contractile responses in rat blood vessels.
M E Berger, M S Golub, C T Chang, J A al-Kharouf, M D Nyby, M Hori, A S Brickman and M L Tuck

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 78-83;
You have access
Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.
M K James, A Vuong, M K Grizzle, S V Schuster and J E Shaffer

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 84-91;
You have access
Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
T L Yue, H Y Cheng, P G Lysko, P J McKenna, R Feuerstein, J L Gu, K A Lysko, L L Davis and G Feuerstein

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 92-98;
You have access
Effects of beta-endorphin on mu and delta opioid receptor-coupled G-protein activity: low-Km GTPase studies.
D E Selley and J M Bidlack

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 99-104;
You have access
Dose-dependent toxicokinetics of L-689,502, a potent human immunodeficiency virus protease inhibitor, in rats and dogs.
J H Lin, I W Chen and J King

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 105-111;
You have access
A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin.
T Godfraind, C Dessy and S Salomone

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 112-122;
You have access
Serotonin-induced relaxation in canine coronary artery smooth muscle.
D J Cushing and M L Cohen

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 123-129;
You have access
Pulmonary accumulation of propranolol in vivo: sites and physiochemical mechanism.
R E Howell and P N Lanken

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 130-135;
You have access
Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat.
A B Malmberg and T L Yaksh

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 136-146;
You have access
Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.
F Porreca, A E Takemori, M Sultana, P S Portoghese, W D Bowen and H I Mosberg

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 147-152;
You have access
Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose.
B Tesfamariam, M L Brown and R A Cohen

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 153-157;
You have access
Enhanced blood pressure and renal hemodynamic effect of chronic versus acute lisinopril administration in the rabbit.
A F Hajj-Ali and B G Zimmerman

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 158-162;
You have access
Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity.
G D Pennock, T E Raya, J J Bahl, S Goldman and E Morkin

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 163-169;
You have access
Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.
N Marczin, U S Ryan and J D Catravas

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 170-179;
You have access
The effect of the atypical antipsychotic drug, amperozide, on carrier-mediated striatal dopamine release measured in vivo.
B K Yamamoto and H Y Meltzer

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 180-185;
You have access
Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13.
J S Strobl and V A Peterson

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 186-193;
You have access
On the mechanism of papaverine inhibition of the voltage-dependent Ca++ current in isolated smooth muscle cells from the guinea pig trachea.
M Iguchi, T Nakajima, T Hisada, T Sugimoto and Y Kurachi

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 194-200;
You have access
Characterization of [3H]YM617, R-(-)-5-[2-[[2[ethoxyring(n)-3H](o-ethoxyphenoxy)ethyl]amino]- propyl]-2-methoxybenzenesulfonamide HCl, a potent and selective alpha-1 adrenoceptor radioligand.
H Yazawa, M Takanashi, K Sudoh, O Inagaki and K Honda

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 201-206;
You have access
Block of voltage-gated potassium currents by anticonvulsant U-54494A in mouse neuroblastoma cells.
Y Zhu, H K Im and W B Im

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 207-213;
You have access
Selective inhibitory effects of calcium channel antagonists on the two components of the neurogenic response of guinea pig vas deferens.
F Hata, A Fujita, K Saeki, I Kishi, T Takeuchi and O Yagasaki

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 214-220;
You have access
Specific inhibition of isoproterenol-stimulated cyclic AMP accumulation by M2 muscarinic receptors in rat intestinal smooth muscle.
M T Griffin and F J Ehlert

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 221-225;
You have access
Prejunctional muscarinic receptors in the deep muscular plexus of canine ileum: comparison with smooth muscle receptors.
P Kostka, S Ahmad, C Y Kwan, E E Daniel, R K Gordon and P K Chiang

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 226-231;
You have access
Lipid solubility of sedative-hypnotic drugs influences hypothermic and hypnotic responses of long-sleep and short-sleep mice.
N C De Fiebre, R J Marley, J M Wehner and A C Collins

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 232-240;
You have access
Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells.
S Oda, T Sano, Y Morishita and Y Matsuda

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 241-245;
You have access
Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
J Y Xu, J M Fujimoto and L F Tseng

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 246-252;
You have access
Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
M F Jarvis, G W Gessner, G E Martin, M Jaye, M W Ravera and C A Dionne

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 253-263;
You have access
Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
A B Malmberg and T L Yaksh

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 264-275;
You have access
The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
E M Hoenicke, S A Vanecek and J H Woods

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 276-284;
You have access
Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor.
S W Kerr, L V Buchanan, S Bunting and W R Mathews

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 285-292;
You have access
Gentamicin-induced hypercalciuria in the rat: assessment of nephron site involved.
H O Garland, D J Phipps and E S Harpur

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 293-297;
You have access
Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem.
G Perrault, E Morel, D J Sanger and B Zivkovic

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 298-303;
You have access
S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
M Garbarg, J M Arrang, A Rouleau, X Ligneau, M D Tuong, J C Schwartz and C R Ganellin

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 304-310;
You have access
Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
T W Moody, J Staley, F Zia, D H Coy and R T Jensen

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 311-317;
You have access
Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
C W Callaway and M A Geyer

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 318-326;
You have access
N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation.
A Pittaluga and M Raiteri

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 327-333;
You have access
In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase.
Z Hu and P G Wells

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 334-342;
You have access
Chronic cocaine treatment suppresses basal expression of zif268 in rat forebrain: in situ hybridization studies.
R V Bhat, A J Cole and J M Baraban

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 343-349;
You have access
Comparison of 5-hydroxytryptamine1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells.
S G Beck, K C Choi and T J List

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 350-359;
You have access
Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.
J S Leeder, R J Riley, V A Cook and S P Spielberg

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 360-367;
You have access
Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis.
X Z Ding and I Mocchetti

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 368-373;
You have access
Gastroprotective effects of thromboxane receptor antagonists.
M L Ogletree, E H O'Keefe, S K Durham, B Rubin and G Aberg

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 374-380;
You have access
Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
H Sakai, T Okamoto and Y Kikkawa

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 381-386;
You have access
Ca(++)-activated DNA fragmentation and dimethylnitrosamine-induced hepatic necrosis: effects of Ca(++)-endonuclease and poly(ADP-ribose) polymerase inhibitors in mice.
S D Ray, C L Sorge, L M Kamendulis and G B Corcoran

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 387-394;
You have access
The role of adrenergic receptors in the initiation of vomiting and its gastrointestinal motor correlates.
I M Lang and S K Sarna

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 395-403;
You have access
Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture.
C R Albrightson, P Nambi, B Zabko-Potapovich, G Dytko and T Groom

Journal of Pharmacology and Experimental Therapeutics October 1992, 263 (1) 404-412;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals